AURORA SPINE CORP (ASG.CA) Stock Fundamental Analysis
Canada - TSX-V:ASG - CA05206X1087 - Common Stock
0.3 CAD
-0.03 (-7.69%)
ASG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Equipment & Supplies industry. While ASG seems to be doing ok healthwise, there are quite some concerns on its profitability. ASG has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year ASG has reported negative net income.
In the past year ASG had a positive cash flow from operations.
In the past 5 years ASG always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ASG reported negative operating cash flow in multiple years.
1.2 Ratios
ASG's Return On Assets of -9.77% is amongst the best of the industry. ASG outperforms 93.33% of its industry peers.
The Return On Equity of ASG (-28.62%) is better than 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.77% | ||
| ROE | -28.62% | ||
| ROIC | N/A |
ROA(3y)-12.48%
ROA(5y)-12.6%
ROE(3y)-29.77%
ROE(5y)-27.75%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ASG has a better Gross Margin (59.64%) than 66.67% of its industry peers.
In the last couple of years the Gross Margin of ASG has grown nicely.
The Profit Margin and Operating Margin are not available for ASG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5Y13.74%
2. Health
2.1 Basic Checks
ASG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASG has been increased compared to 1 year ago.
ASG has more shares outstanding than it did 5 years ago.
ASG has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.26, we must say that ASG is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ASG (0.26) is better than 80.00% of its industry peers.
ASG has a debt to FCF ratio of 18.86. This is a negative value and a sign of low solvency as ASG would need 18.86 years to pay back of all of its debts.
ASG has a better Debt to FCF ratio (18.86) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.84 indicates that ASG is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.84, ASG perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | 18.86 | ||
| Altman-Z | 0.26 |
ROIC/WACCN/A
WACC6.93%
2.3 Liquidity
ASG has a Current Ratio of 2.03. This indicates that ASG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.03, ASG belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that ASG should not have too much problems paying its short term obligations.
ASG has a better Quick ratio (1.13) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.03 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The earnings per share for ASG have decreased strongly by -13.18% in the last year.
Looking at the last year, ASG shows a quite strong growth in Revenue. The Revenue has grown by 14.28% in the last year.
ASG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.51% yearly.
EPS 1Y (TTM)-13.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
Revenue 1Y (TTM)14.28%
Revenue growth 3Y18.54%
Revenue growth 5Y9.51%
Sales Q2Q%10.24%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ASG. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
86.67% of the companies in the same industry are more expensive than ASG, based on the Enterprise Value to EBITDA ratio.
ASG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ASG is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 85.79 | ||
| EV/EBITDA | 64.9 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ASG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:ASG (11/13/2025, 7:00:00 PM)
0.3
-0.03 (-7.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0%
Inst Owner ChangeN/A
Ins Owners25.16%
Ins Owner ChangeN/A
Market Cap23.17M
Revenue(TTM)18.38M
Net Income(TTM)-1.13M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.9 | ||
| P/FCF | 85.79 | ||
| P/OCF | 22.96 | ||
| P/B | 4.18 | ||
| P/tB | 5.16 | ||
| EV/EBITDA | 64.9 |
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY1.17%
OCF(TTM)0.01
OCFY4.36%
SpS0.33
BVpS0.07
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.77% | ||
| ROE | -28.62% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.64% | ||
| FCFM | 1.05% |
ROA(3y)-12.48%
ROA(5y)-12.6%
ROE(3y)-29.77%
ROE(5y)-27.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5Y13.74%
F-Score3
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | 18.86 | ||
| Debt/EBITDA | 11.04 | ||
| Cap/Depr | 50.45% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 238.59% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.03 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 0.26 |
F-Score3
WACC6.93%
ROIC/WACCN/A
Cap/Depr(3y)69.84%
Cap/Depr(5y)82.94%
Cap/Sales(3y)4.27%
Cap/Sales(5y)5.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.28%
Revenue growth 3Y18.54%
Revenue growth 5Y9.51%
Sales Q2Q%10.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y124.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y355.27%
OCF growth 3YN/A
OCF growth 5Y319.03%
AURORA SPINE CORP / ASG.CA FAQ
What is the ChartMill fundamental rating of AURORA SPINE CORP (ASG.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to ASG.CA.
What is the valuation status for ASG stock?
ChartMill assigns a valuation rating of 2 / 10 to AURORA SPINE CORP (ASG.CA). This can be considered as Overvalued.
How profitable is AURORA SPINE CORP (ASG.CA) stock?
AURORA SPINE CORP (ASG.CA) has a profitability rating of 3 / 10.